Literature DB >> 26330012

The Society of Thoracic Surgeons Composite Measure of Individual Surgeon Performance for Adult Cardiac Surgery: A Report of The Society of Thoracic Surgeons Quality Measurement Task Force.

David M Shahian1, Xia He2, Jeffrey P Jacobs3, Paul A Kurlansky4, Vinay Badhwar5, Joseph C Cleveland6, Frank L Fazzalari7, Giovanni Filardo8, Sharon-Lise T Normand9, Anthony P Furnary10, Mitchell J Magee11, J Scott Rankin12, Karl F Welke13, Jane Han14, Sean M O'Brien2.   

Abstract

BACKGROUND: Previous composite performance measures of The Society of Thoracic Surgeons (STS) were estimated at the STS participant level, typically a hospital or group practice. The STS Quality Measurement Task Force has now developed a multiprocedural, multidimensional composite measure suitable for estimating the performance of individual surgeons.
METHODS: The development sample from the STS National Database included 621,489 isolated coronary artery bypass grafting procedures, isolated aortic valve replacement, aortic valve replacement plus coronary artery bypass grafting, mitral, or mitral plus coronary artery bypass grafting procedures performed by 2,286 surgeons between July 1, 2011, and June 30, 2014. Each surgeon's composite score combined their aggregate risk-adjusted mortality and major morbidity rates (each weighted inversely by their standard deviations) and reflected the proportion of case types they performed. Model parameters were estimated in a Bayesian framework. Composite star ratings were examined using 90%, 95%, or 98% Bayesian credible intervals. Measure reliability was estimated using various 3-year case thresholds.
RESULTS: The final composite measure was defined as 0.81 × (1 minus risk-standardized mortality rate) + 0.19 × (1 minus risk-standardized complication rate). Risk-adjusted mortality (median, 2.3%; interquartile range, 1.7% to 3.0%), morbidity (median, 13.7%; interquartile range, 10.8% to 17.1%), and composite scores (median, 95.4%; interquartile range, 94.4% to 96.3%) varied substantially across surgeons. Using 98% Bayesian credible intervals, there were 207 1-star (lower performance) surgeons (9.1%), 1,701 2-star (as-expected performance) surgeons (74.4%), and 378 3-star (higher performance) surgeons (16.5%). With an eligibility threshold of 100 cases over 3 years, measure reliability was 0.81.
CONCLUSIONS: The STS has developed a multiprocedural composite measure suitable for evaluating performance at the individual surgeon level.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26330012     DOI: 10.1016/j.athoracsur.2015.06.122

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Geographically Derived Socioeconomic Factors to Improve Risk Prediction in Patients Having Aortic Valve Replacement.

Authors:  Fenton H McCarthy; Lingjiao Zhang; Vicky Tam; Jinbo Chen; Chase Brown; William L Patrick; Walter Clark Hargrove; Wilson Y Szeto; Nimesh D Desai; Douglas J Wiebe; Peter W Groeneveld; Matthew L Williams
Journal:  Am J Cardiol       Date:  2018-09-26       Impact factor: 2.778

2.  Evaluating Surgeon-Specific Performance for Endoscopic Sinus Surgery.

Authors:  Luke Rudmik; Yuan Xu; Jeremiah A Alt; Adam Deconde; Timothy L Smith; Rodney J Schlosser; Hude Quan; Zachary M Soler
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-09-01       Impact factor: 6.223

3.  Reduced Echocardiographic Inotropy Index after Cardiopulmonary Bypass Is Associated With Complications After Cardiac Surgery: An Institutional Outcomes Study.

Authors:  Michael R Mathis; Neal M Duggal; Allison M Janda; Jordan L Fennema; Bo Yang; Francis D Pagani; Michael D Maile; Ryan E Hofer; Elizabeth S Jewell; Milo C Engoren
Journal:  J Cardiothorac Vasc Anesth       Date:  2021-01-27       Impact factor: 2.894

Review 4.  Closing the loop: a 10-year experience with routine outcome measurements to improve treatment in hand surgery.

Authors:  Reinier Feitz; Yara E van Kooij; Marloes H P Ter Stege; Mark J W van der Oest; J Sebastiaan Souer; Robbert M Wouters; Harm P Slijper; Ruud W Selles; Steven E R Hovius
Journal:  EFORT Open Rev       Date:  2021-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.